Home › Calculator › SNYNF Dividend Calculator 2026
SNYNF Dividend DRIP Calculator 2026
5.68% YieldHealthcareSanofi · OTC
Price: $85.25 · Annual div: $4.84/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When SNYNF pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your SNYNF snowball 📈
$10,000 in SNYNF → $121.1K in 10 years · $771.29/month
About Sanofi (SNYNF) — Dividend Analysis 2026
Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases neurology, oncology, and other vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines that includes hepatitis A, typhoid, yellow fever, and rabies vaccines. It has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301 for treatment of alpha-synucleinopathies; and Innate Pharma SA for cell engager program targeting B7-H3. Further, it has a collaboration agreements with Atomwise to use ATOMNET platform and Insilico Medicine to use Pharma.AI, a medicine's AI platform; Kymera Therapeutics, Inc. to develop and commercialize protein degrader therapies targeting IRAK4 in patients with immune-inflammatory diseases; Nurix Therapeutics, Inc. to develop protein degradation therapies; Denali Therapeutics Inc. to treat systemic inflammatory diseases, such as ulcerative colitis; and Adagene Inc. for development of antibody-based therapies. Additionally, it has a collaboration with Scribe Therapeutics Inc. to develop genome editing technologies; Teva Pharmaceuticals to co-develop and co-commercialize TEV'574, for treatment of ulcerative colitis and Crohn's disease; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incorporated in 1994 and is headquartered in Paris, France.
Compare SNYNF with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full SNYNF DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open SNYNF position with:
🌍 SNYNF Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold SNYNF.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 5.68% | 2.88% | $568 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 4.83% | 2.03% | $483 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 4.54% | 1.74% | $454 / yr |
| 🇬🇧 UK ISA | 0% | 5.68% | 2.88% | $568 / yr |
| 🇬🇧 UK Taxable | 8.75% | 5.18% | 2.38% | $518 / yr |
| 🇨🇦 TFSA | 0% | 5.68% | 2.88% | $568 / yr |
| 🇨🇦 CA Taxable | 25% | 4.26% | 1.46% | $426 / yr |
| 🇦🇺 Super (pension) | 15% | 4.83% | 2.03% | $483 / yr |
| 🇦🇺 AU Taxable | 30% | 3.98% | 1.18% | $398 / yr |
| 🇩🇪 DE Taxable | 26.375% | 4.18% | 1.38% | $418 / yr |
| 🇫🇷 FR Taxable | 30% | 3.98% | 1.18% | $398 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 SNYNF Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $4.84/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 SNYNF Dividend Payment Schedule
SNYNF pays quarterly — 4 times per year. Next ex-div: TBD.
📊 SNYNF vs Healthcare Benchmarks
How SNYNF compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for SNYNF sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ SNYNF Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| Buy | 2014-07-10 | 17,286 | $314.58 | $5.44M | ||
| Buy | 2014-07-10 | 18,057 | $313.47 | $5.66M | ||
| Buy | 2014-07-10 | 20,638 | $312.62 | $6.45M | ||
| Buy | 2014-07-10 | 15,815 | $311.17 | $4.92M | ||
| Buy | 2014-07-10 | 53,994 | $310.48 | $16.76M | ||
| Buy | 2014-07-10 | 26,891 | $309.56 | $8.32M | ||
| Buy | 2014-07-10 | 17,347 | $308.55 | $5.35M | ||
| Buy | 2014-07-10 | 2,502 | $307.64 | $769.7K | ||
| Buy | 2014-07-10 | 2,470 | $306.77 | $757.7K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Geographic Revenue Breakdown
Where SNYNF earns its moneyRevenue breakdown from latest annual report via FMP. Percentages may not sum to 100% due to rounding.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the SNYNF dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Sanofi (SNYNF) is currently trading at $85.25, 29% below its 52-week high. The current dividend yield is 5.68% based on an annual payout of $4.84 per share.
SNYNF (Sanofi) — 5.68% Dividend Yield Analysis
Sanofi (SNYNF) is a healthcare stock currently trading at $85.25 with a dividend yield of 5.68%. The company pays an annual dividend of $4.84 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings. Over the past 5 years, SNYNF has grown its dividend at a compound annual rate of 24.5%.
- Dividend payments are not guaranteed and can be reduced or suspended at any time.
Auto-generated from live market data. For educational purposes only — not financial advice.
Latest SNYNF News
LiveNews aggregated from public sources via Finnhub & RSS. For informational purposes only.